Gastroenterology Handbook
For UK audiences

The essential guide to product selection

Biologics

Adalimumab (Amgevita)
Amgen

Adalimumab (Amgevita)

Biosimilar of adalimumab (Humira) – see listing for indications, contraindications, side effects and dose

Adalimumab (Humira)
AbbVie

Adalimumab (Humira)

Tumour necrosis factor (TNF) antagonist (anti-TNF)

Adalimumab (Hyrimoz)
Sandoz

Adalimumab (Hyrimoz)

Biosimilar of adalimumab (Humira) – see listing for indications, contraindications, side effects and dose

Adalimumab (Idacio)
Fresenius Kabi

Adalimumab (Idacio)

Biosimilar of adalimumab (Humira) – see listing for indications, contraindications, side effects and dose

Adalimumab (Imraldi)
Biogen Idec

Adalimumab (Imraldi)

Biosimilar of adalimumab (Humira) – see listing for indications, contraindications, side effects and dose

Adalimumab (Yuflyma)
Celltrion Healthcare

Adalimumab (Yuflyma)

Biosimilar of adalimumab (Humira) – see listing for indications, contraindications, side effects and dose

Etrasimod (Velsipity)
AbbVie

Etrasimod (Velsipity)

Sphingosine-1-phosphate receptor modulator

Golimumab (Simponi)
Merck Sharp & Dohme

Golimumab (Simponi)

Tumour necrosis factor (TNF) antagonist (anti-TNF)

Infliximab (Flixabi)
Biogen Idec

Infliximab (Flixabi)

Biosimilar of infliximab (Remicade) – see listing for indications, contraindications, side effects and dose

Infliximab (Inflectra)
Pfizer

Infliximab (Inflectra)

Biosimilar of infliximab (Remicade) – see listing for indications, contraindications, side effects and dose

Infliximab (Remicade)
Merck Sharp & Dohme

Infliximab (Remicade)

Tumour necrosis factor (TNF) antagonist (anti-TNF)

Infliximab (Remsima)
Celltrion Healthcare

Infliximab (Remsima)

Biosimilar of infliximab (Remicade) – see listing for indications, contraindications, side effects and dose

Infliximab (Zessly)
Sandoz

Infliximab (Zessly)

Biosimilar of infliximab (Remicade) – see listing for indications, contraindications, side effects and dose

Mirikizumab (Omvoh)
Lilly

Mirikizumab (Omvoh)

Interleukin-23 antagonist (anti-interleukin)

Risankizumab (Skyrizi)
Pfizer

Risankizumab (Skyrizi)

Interleukin-23 antagonist (anti-interleukin)

Ustekinumab (Stelara)
Janssen-Cilag

Ustekinumab (Stelara)

Interleukin-12/23 antagonist (anti-interleukin)

Vedolizumab (Entyvio)
Takeda

Vedolizumab (Entyvio)

Gut-selective integrin blocker (anti-integrin)